|
Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.This report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
|
|
Hologic has received correspondence arising from litigation.The litigation alleges that a patient received a biozorb implant post lumpectomy on (b)(6) 2022.It is alleged that the patient developed complications at the lumpectomy site, which include mastitis, abscess, redness, swelling, pain, chills and purulent drainage.Additionally, it is reported that the patient was hospitalized from (b)(6) 2025, with a diagnosis of mastitis and abscess and underwent an incision and drainage procedure.It is reported that "clips from the prior biozorb were removed during the i&d procedure." this report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
|